Midazolam

Midazolam is given to children before medical procedures or before anesthesia for surgery to cause drowsiness, relieve anxiety, and prevent any memory of the event. Midazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow relaxation and sleep.

Midazolam comes as a syrup to take by mouth. It is usually given as a single dose by a doctor or nurse before a medical procedure or surgery.

This medication may be prescribed for other uses; ask your child's doctor or pharmacist for more information.

Before your child receives midazolam,

• tell your child's doctor and pharmacist if he or she is allergic to midazolam, any other medications, or cherries.

• tell your child's doctor if your child is taking certain medications for human immunodeficiency virus (HIV) including amprenavir (Agenerase), atazanavir (Reyataz), darunavir (Prezista), delavirdine (Rescriptor), efavirenz (Sustiva, in Atripla), fosamprenavir (Lexiva), indinavir (Crixivan),lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), saquinavir (Invirase), and tipranavir (Aptivus). Your child's doctor may decide not to give midazolam to your child if he or she is taking one or more of these medications.

• tell your child's doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements your child is taking or plans to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: amiodarone (Cordarone, Pacerone); aminophylline (Truphylline); antifungals such as fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); certain calcium channel blockers such as diltiazem (Cartia, Cardizem, Tiazac, others) and verapamil (Calan, Isoptin, Verelan, others); cimetidine (Tagamet); clarithromycin (Biaxin); dalfopristin-quinupristin (Synercid); erythromycin (E-mycin, E.E.S.); fluvoxamine (Luvox); certain medications for seizures such as carbamazepine (Tegretol), phenobarbital, and phenytoin (Dilantin); methylphenidate (Concerta, Metadate, Ritalin, others); nefazodone; ranitidine (Zantac); rifabutin (Mycobutin); and rifampin (Rifadin, Rimactane). Your child's doctor may need to change the doses of your child's medications or monitor your child carefully for side effects. Many other medications may also interact with midazolam, so be sure to tell your child's doctor about all the medications your child is taking, even those that do not appear on this list.

• tell your child's doctor what herbal products your child is taking, especially St. John's wort.

• tell your child's doctor if your child has glaucoma. Your child's doctor may decide not to give your child midazolam.

• tell your child's doctor if your child has or has ever had kidney or liver disease.

• tell your child's doctor if your child is or may be pregnant, or is breast-feeding.

• you should know that midazolam may make your child very drowsy and may affect his or her memory, thinking, and movements. Do not allow your child to ride a bicycle, drive a car, or do other activities that require him or her to be fully alert for at least 24 hours after receiving midazolam and until the effects of the medication have worn off. Watch your child carefully to be sure that he or she does not fall while walking during this time.

• you should know that alcohol can make the side effects of midazolam worse.

Do not let your child eat grapefruit or drink grapefruit juice while taking this medication.

• Midazolam may cause side effects. Tell your child's doctor if any of these symptoms are severe or do not go away:

  • nausea

  • vomiting

  • rash

• Some side effects can be serious. If your child experiences any of these symptoms, call his or her doctor immediately:

  • agitation

  • restlessness

  • uncontrollable shaking of a part of the body

  • stiffening and jerking of the arms and legs

  • aggression

  • slow or irregular heartbeat

• Midazolam may cause other side effects. Call your child's doctor if your child has any unusual problems while taking this medication.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

• drowsiness

• confusion

• problems with balance and movement

• slowed breathing and heartbeat

• loss of consciousness

Keep all appointments with your child's doctor.

Ask your child's pharmacist or doctor if you have any questions about midazolam.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines your child is taking, as well as many products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time your child visits a doctor or if he or she is admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Delavirdine	Delavirdine The serum concentration of Midazolam can be increased when it is combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Midazolam can be decreased when combined with Nevirapine.
Atorvastatin	Atorvastatin The serum concentration of Midazolam can be increased when it is combined with Atorvastatin.
Dolasetron	Dolasetron The risk or severity of adverse effects can be increased when Midazolam is combined with Dolasetron.
Aminophylline	Aminophylline The metabolism of Aminophylline can be decreased when combined with Midazolam.
Cilostazol	Cilostazol The metabolism of Cilostazol can be decreased when combined with Midazolam.
Clopidogrel	Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Midazolam.
Diphenoxylate	Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Midazolam.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The serum concentration of Midazolam can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Midazolam which could result in a higher serum level.
Fenofibrate	Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Midazolam.
Guanfacine	Guanfacine The risk or severity of adverse effects can be increased when Midazolam is combined with Guanfacine.
Magnesium Hydroxide	Magnesium Hydroxide Midazolam may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine	Methylergonovine The serum concentration of Midazolam can be increased when it is combined with Methylergometrine.
Mycophenolate	Mycophenolate Midazolam may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan	Naratriptan The risk or severity of adverse effects can be increased when Midazolam is combined with Naratriptan.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Paregoric	Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Midazolam.
Pentazocine	Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Midazolam.
Potassium	Potassium Potassium may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone Prednisone may decrease the excretion rate of Midazolam which could result in a higher serum level.
Ranitidine	Ranitidine The serum concentration of Ranitidine can be increased when it is combined with Midazolam.
Reserpine	Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Midazolam.
Rizatriptan	Rizatriptan The risk or severity of adverse effects can be increased when Midazolam is combined with Rizatriptan.
Sumatriptan	Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Midazolam.
Tacrolimus	Tacrolimus The serum concentration of Midazolam can be increased when it is combined with Tacrolimus.
Tizanidine	Tizanidine The risk or severity of adverse effects can be increased when Midazolam is combined with Tizanidine.
Triamcinolone	Triamcinolone The metabolism of Midazolam can be increased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Midazolam.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Midazolam which could result in a higher serum level.
Fluconazole Injection	Fluconazole Injection The serum concentration of Midazolam can be increased when it is combined with Fluconazole.
Foscarnet Injection	Foscarnet Injection Foscarnet may decrease the excretion rate of Midazolam which could result in a higher serum level.
Hydromorphone Injection	Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Midazolam.
Levofloxacin Injection	Levofloxacin Injection Midazolam may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection	Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Midazolam.
Metoclopramide Injection	Metoclopramide Injection The risk or severity of sedation can be increased when Midazolam is combined with Metoclopramide.
Metronidazole Injection	Metronidazole Injection The serum concentration of Midazolam can be increased when it is combined with Metronidazole.
Morphine Injection	Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Midazolam.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Midazolam may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine	Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Midazolam.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cyclosporine	Cyclosporine The serum concentration of Midazolam can be increased when it is combined with Cyclosporine.
Ondansetron	Ondansetron The risk or severity of adverse effects can be increased when Midazolam is combined with Ondansetron.
Granisetron	Granisetron The risk or severity of adverse effects can be increased when Midazolam is combined with Granisetron.
Torsemide	Torsemide Torasemide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine	Olanzapine The risk or severity of adverse effects can be increased when Midazolam is combined with Olanzapine.
Alosetron	Alosetron The risk or severity of adverse effects can be increased when Midazolam is combined with Alosetron.
Dofetilide	Dofetilide The metabolism of Midazolam can be decreased when combined with Dofetilide.
Entacapone	Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Midazolam.
Meloxicam	Meloxicam Meloxicam may decrease the excretion rate of Midazolam which could result in a higher serum level.
Oxcarbazepine	Oxcarbazepine The serum concentration of Midazolam can be increased when it is combined with Oxcarbazepine.
Pantoprazole	Pantoprazole Pantoprazole may decrease the excretion rate of Midazolam which could result in a higher serum level.
Temozolomide	Temozolomide Midazolam may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon	Zaleplon The risk or severity of adverse effects can be increased when Midazolam is combined with Zaleplon.
Anakinra	Anakinra The metabolism of Midazolam can be increased when combined with Anakinra.
Desloratadine	Desloratadine The risk or severity of adverse effects can be increased when Midazolam is combined with Desloratadine.
Linezolid	Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Midazolam.
Trimipramine	Trimipramine The risk or severity of adverse effects can be increased when Midazolam is combined with Trimipramine.
Etanercept Injection	Etanercept Injection The metabolism of Midazolam can be increased when combined with Etanercept.
Glycopyrrolate	Glycopyrrolate Midazolam may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil	Modafinil The metabolism of Midazolam can be increased when combined with Modafinil.
Perindopril	Perindopril Midazolam may decrease the excretion rate of Perindopril which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Midazolam which could result in a higher serum level.
Sirolimus	Sirolimus The serum concentration of Midazolam can be increased when it is combined with Sirolimus.
Dutasteride	Dutasteride The metabolism of Dutasteride can be decreased when combined with Midazolam.
Epinephrine Injection	Epinephrine Injection The serum concentration of Midazolam can be increased when it is combined with Epinephrine.
Eplerenone	Eplerenone Midazolam may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram	Escitalopram The risk or severity of adverse effects can be increased when Escitalopram is combined with Midazolam.
Zonisamide	Zonisamide Midazolam may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection	Adalimumab Injection The metabolism of Midazolam can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Midazolam.
Atomoxetine	Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Midazolam.
Dexmethylphenidate	Dexmethylphenidate The risk or severity of adverse effects can be increased when Midazolam is combined with Dexmethylphenidate.
Atazanavir	Atazanavir The serum concentration of Midazolam can be increased when it is combined with Atazanavir.
Almotriptan	Almotriptan The risk or severity of adverse effects can be increased when Midazolam is combined with Almotriptan.
Eletriptan	Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Midazolam.
Mefloquine	Mefloquine The serum concentration of Midazolam can be increased when it is combined with Mefloquine.
Rosuvastatin	Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Midazolam.
Vardenafil	Vardenafil The metabolism of Vardenafil can be decreased when combined with Midazolam.
Alfuzosin	Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Midazolam.
Aprepitant	Aprepitant The serum concentration of Midazolam can be increased when it is combined with Aprepitant.
Emtricitabine	Emtricitabine Midazolam may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine	Memantine Midazolam may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil	Tadalafil Midazolam may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan	Frovatriptan The risk or severity of adverse effects can be increased when Midazolam is combined with Frovatriptan.
Progesterone	Progesterone The metabolism of Midazolam can be decreased when combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The risk or severity of adverse effects can be increased when Midazolam is combined with Apomorphine.
Infliximab Injection	Infliximab Injection The metabolism of Midazolam can be increased when combined with Infliximab.
Protriptyline	Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Midazolam.
Duloxetine	Duloxetine The serum concentration of Midazolam can be increased when it is combined with Duloxetine.
Norethindrone	Norethindrone The metabolism of Norethisterone can be decreased when combined with Midazolam.
Tinidazole	Tinidazole Midazolam may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium	Trospium Midazolam may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Erlotinib	Erlotinib The serum concentration of Midazolam can be increased when it is combined with Erlotinib.
Eszopiclone	Eszopiclone The risk or severity of CNS depression can be increased when Midazolam is combined with Eszopiclone.
Ganciclovir	Ganciclovir Midazolam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin	Ribavirin Midazolam may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin	Solifenacin Midazolam may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir	Valganciclovir Midazolam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole	Voriconazole The serum concentration of Midazolam can be increased when it is combined with Voriconazole.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Midazolam.
Sodium Oxybate	Sodium Oxybate Midazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Isocarboxazid	Isocarboxazid The risk or severity of adverse effects can be increased when Midazolam is combined with Isocarboxazid.
Ramelteon	Ramelteon The risk or severity of adverse effects can be increased when Midazolam is combined with Ramelteon.
Darifenacin	Darifenacin Midazolam may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl	Fentanyl The metabolism of Fentanyl can be decreased when combined with Midazolam.
Pregabalin	Pregabalin The therapeutic efficacy of Midazolam can be increased when used in combination with Pregabalin.
Phenylephrine	Phenylephrine The risk or severity of hypertension can be decreased when Midazolam is combined with Phenylephrine.
Tipranavir	Tipranavir The serum concentration of Midazolam can be increased when it is combined with Tipranavir.
Felbamate	Felbamate The risk or severity of adverse effects can be increased when Midazolam is combined with Felbamate.
Ranolazine	Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Midazolam.
Abatacept Injection	Abatacept Injection The metabolism of Midazolam can be increased when combined with Abatacept.
Rasagiline	Rasagiline The risk or severity of adverse effects can be increased when Midazolam is combined with Rasagiline.
Imatinib	Imatinib The serum concentration of Midazolam can be increased when it is combined with Imatinib.
Sitagliptin	Sitagliptin Midazolam may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline	Varenicline Midazolam may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib	Gefitinib The serum concentration of Midazolam can be increased when it is combined with Gefitinib.
Albuterol	Albuterol Midazolam may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone	Paliperidone The risk or severity of adverse effects can be increased when Midazolam is combined with Paliperidone.
Bortezomib	Bortezomib The metabolism of Bortezomib can be decreased when combined with Midazolam.
Clofarabine Injection	Clofarabine Injection Clofarabine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Lubiprostone	Lubiprostone Midazolam may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Posaconazole	Posaconazole The serum concentration of Midazolam can be increased when it is combined with Posaconazole.
Primaquine	Primaquine The serum concentration of Midazolam can be increased when it is combined with Primaquine.
Darunavir	Darunavir The serum concentration of Midazolam can be increased when it is combined with Darunavir.
Pemetrexed Injection	Pemetrexed Injection Midazolam may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate	Dimenhydrinate The risk or severity of adverse effects can be increased when Midazolam is combined with Dimenhydrinate.
Nabilone	Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Retapamulin	Retapamulin The metabolism of Retapamulin can be decreased when combined with Midazolam.
Sorafenib	Sorafenib The serum concentration of Midazolam can be increased when it is combined with Sorafenib.
Sunitinib	Sunitinib The serum concentration of Midazolam can be increased when it is combined with Sunitinib.
Dronabinol	Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Lapatinib	Lapatinib The serum concentration of Midazolam can be increased when it is combined with Lapatinib.
Levocetirizine	Levocetirizine The risk or severity of adverse effects can be increased when Midazolam is combined with Levocetirizine.
Pegaptanib Injection	Pegaptanib Injection Midazolam may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The serum concentration of Midazolam can be increased when it is combined with Dasatinib.
Armodafinil	Armodafinil The metabolism of Midazolam can be increased when combined with Armodafinil.
Azacitidine Injection	Azacitidine Injection Midazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Temsirolimus	Temsirolimus The serum concentration of Midazolam can be increased when it is combined with Temsirolimus.
Lenalidomide	Lenalidomide Lenalidomide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Nilotinib	Nilotinib The serum concentration of Midazolam can be increased when it is combined with Nilotinib.
Budesonide	Budesonide The metabolism of Midazolam can be increased when combined with Budesonide.
Chloramphenicol Injection	Chloramphenicol Injection The serum concentration of Midazolam can be increased when it is combined with Chloramphenicol.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Midazolam which could result in a higher serum level.
OnabotulinumtoxinA Injection	OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Midazolam.
RimabotulinumtoxinB Injection	RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midazolam.
Doripenem Injection	Doripenem Injection Midazolam may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection	Arsenic Trioxide Injection Midazolam may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Mitoxantrone Injection	Mitoxantrone Injection The serum concentration of Midazolam can be increased when it is combined with Mitoxantrone.
Desvenlafaxine	Desvenlafaxine The serum concentration of Midazolam can be increased when it is combined with Desvenlafaxine.
Cevimeline	Cevimeline Cevimeline may decrease the excretion rate of Midazolam which could result in a higher serum level.
Tretinoin	Tretinoin The metabolism of Tretinoin can be decreased when combined with Midazolam.
Pilocarpine	Pilocarpine The serum concentration of Midazolam can be increased when it is combined with Pilocarpine.
Certolizumab Injection	Certolizumab Injection The metabolism of Midazolam can be increased when combined with Certolizumab pegol.
Ixabepilone Injection	Ixabepilone Injection The serum concentration of Ixabepilone can be increased when it is combined with Midazolam.
Irinotecan Injection	Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Midazolam.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Praziquantel	Praziquantel The metabolism of Praziquantel can be decreased when combined with Midazolam.
Methylnaltrexone Injection	Methylnaltrexone Injection Midazolam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide	Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Midazolam.
Naltrexone Injection	Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Midazolam.
Dexrazoxane Injection	Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Midazolam which could result in a higher serum level.
Eltrombopag	Eltrombopag The metabolism of Midazolam can be decreased when combined with Eltrombopag.
Milnacipran	Milnacipran The serum concentration of Midazolam can be increased when it is combined with Milnacipran.
Plerixafor Injection	Plerixafor Injection Midazolam may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine	Fesoterodine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Iloperidone	Iloperidone The metabolism of Iloperidone can be decreased when combined with Midazolam.
Prasugrel	Prasugrel Midazolam may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide	Lacosamide The risk or severity of adverse effects can be increased when Midazolam is combined with Lacosamide.
Everolimus	Everolimus The serum concentration of Midazolam can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) The metabolism of Midazolam can be decreased when combined with Tolvaptan.
Dronedarone	Dronedarone The serum concentration of Midazolam can be increased when it is combined with Dronedarone.
AbobotulinumtoxinA Injection	AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Midazolam.
Pralatrexate Injection	Pralatrexate Injection Midazolam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Midazolam.
Saxagliptin	Saxagliptin Midazolam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection	Telavancin Injection Midazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection	Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Midazolam.
Tapentadol	Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Topotecan	Topotecan The serum concentration of Midazolam can be increased when it is combined with Topotecan.
Golimumab Injection	Golimumab Injection The metabolism of Midazolam can be increased when combined with Golimumab.
Pazopanib	Pazopanib The serum concentration of Midazolam can be increased when it is combined with Pazopanib.
Asenapine	Asenapine The risk or severity of adverse effects can be increased when Midazolam is combined with Asenapine.
Vigabatrin	Vigabatrin The risk or severity of adverse effects can be increased when Midazolam is combined with Vigabatrin.
Albendazole	Albendazole The metabolism of Albendazole can be decreased when combined with Midazolam.
Levonorgestrel	Levonorgestrel The metabolism of Midazolam can be decreased when combined with Levonorgestrel.
Oxymorphone	Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Midazolam.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Midazolam can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine Midazolam may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
IncobotulinumtoxinA Injection	IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Midazolam.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Midazolam.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Midazolam which could result in a higher serum level.
Lurasidone	Lurasidone The risk or severity of adverse effects can be increased when Midazolam is combined with Lurasidone.
Acetaminophen Injection	Acetaminophen Injection The serum concentration of Midazolam can be increased when it is combined with Acetaminophen.
Vilazodone	Vilazodone The risk or severity of adverse effects can be increased when Midazolam is combined with Vilazodone.
Ipilimumab Injection	Ipilimumab Injection Midazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection The serum concentration of Midazolam can be increased when it is combined with Aldesleukin.
Terbutaline Injection	Terbutaline Injection Midazolam may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Busulfan Injection	Busulfan Injection The metabolism of Busulfan can be decreased when combined with Midazolam.
Roflumilast	Roflumilast The metabolism of Roflumilast can be decreased when combined with Midazolam.
Linagliptin	Linagliptin The serum concentration of Midazolam can be increased when it is combined with Linagliptin.
Rilpivirine	Rilpivirine The serum concentration of Midazolam can be increased when it is combined with Rilpivirine.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Midazolam can be decreased when combined with Cyclophosphamide.
Rivaroxaban	Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Midazolam.
Ticagrelor	Ticagrelor The serum concentration of Midazolam can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection The serum concentration of Midazolam can be increased when it is combined with Brentuximab vedotin.
Ruxolitinib	Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Midazolam.
Vandetanib	Vandetanib The metabolism of Vandetanib can be decreased when combined with Midazolam.
Clobazam	Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Midazolam.
Vemurafenib	Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Midazolam.
Ivacaftor	Ivacaftor The serum concentration of Midazolam can be increased when it is combined with Ivacaftor.
Deferiprone	Deferiprone Midazolam may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Midazolam.
Crizotinib	Crizotinib The serum concentration of Midazolam can be increased when it is combined with Crizotinib.
Cabergoline	Cabergoline The serum concentration of Midazolam can be increased when it is combined with Cabergoline.
Naloxone Injection	Naloxone Injection The serum concentration of Midazolam can be increased when it is combined with Naloxone.
Ambrisentan	Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Midazolam.
Fondaparinux Injection	Fondaparinux Injection Fondaparinux may decrease the excretion rate of Midazolam which could result in a higher serum level.
Ezogabine	Ezogabine The risk or severity of adverse effects can be increased when Midazolam is combined with Tiagabine.
Enzalutamide	Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Midazolam.
Mirabegron	Mirabegron Midazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib	Regorafenib The serum concentration of Midazolam can be increased when it is combined with Regorafenib.
Bosutinib	Bosutinib The serum concentration of Midazolam can be increased when it is combined with Bosutinib.
Teduglutide Injection	Teduglutide Injection The serum concentration of Midazolam can be increased when it is combined with Teduglutide.
Tofacitinib	Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Midazolam.
Alogliptin	Alogliptin Midazolam may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Midazolam.
Pomalidomide	Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Midazolam.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The serum concentration of Midazolam can be increased when it is combined with Trastuzumab emtansine.
Apixaban	Apixaban The metabolism of Apixaban can be decreased when combined with Midazolam.
Canagliflozin	Canagliflozin Canagliflozin may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib	Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Midazolam.
Trametinib	Trametinib Midazolam may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran	Levomilnacipran The risk or severity of adverse effects can be increased when Midazolam is combined with Levomilnacipran.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Midazolam which could result in a higher serum level.
Vortioxetine	Vortioxetine The risk or severity of adverse effects can be increased when Midazolam is combined with Vortioxetine.
Perampanel	Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Midazolam.
Lomitapide	Lomitapide The serum concentration of Midazolam can be increased when it is combined with Lomitapide.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Midazolam which could result in a higher serum level.
Simeprevir	Simeprevir The serum concentration of Midazolam can be increased when it is combined with Simeprevir.
Sofosbuvir	Sofosbuvir Midazolam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin Dapagliflozin may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast	Apremilast The metabolism of Midazolam can be increased when combined with Apremilast.
Droxidopa	Droxidopa Midazolam may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib	Ceritinib The serum concentration of Midazolam can be increased when it is combined with Ceritinib.
Siltuximab Injection	Siltuximab Injection The serum concentration of Midazolam can be increased when it is combined with Siltuximab.
Eslicarbazepine	Eslicarbazepine The risk or severity of adverse effects can be increased when Midazolam is combined with Eslicarbazepine.
Idelalisib	Idelalisib The serum concentration of Midazolam can be increased when it is combined with Idelalisib.
Testosterone Injection	Testosterone Injection The metabolism of Midazolam can be decreased when combined with Testosterone.
Vorapaxar	Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Midazolam.
Hydrocodone	Hydrocodone Midazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant	Suvorexant Midazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Edoxaban	Edoxaban Midazolam may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib	Olaparib The serum concentration of Midazolam can be increased when it is combined with Olaparib.
Methamphetamine	Methamphetamine The risk or severity of adverse effects can be increased when Midazolam is combined with Metamfetamine.
Tasimelteon	Tasimelteon The risk or severity of adverse effects can be increased when Midazolam is combined with Tasimelteon.
Lanreotide Injection	Lanreotide Injection The serum concentration of Midazolam can be increased when it is combined with Lanreotide.
Nintedanib	Nintedanib The metabolism of Nintedanib can be decreased when combined with Midazolam.
Secukinumab Injection	Secukinumab Injection The metabolism of Midazolam can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection The risk or severity of adverse effects can be increased when Midazolam is combined with Risperidone.
Palbociclib	Palbociclib The serum concentration of Midazolam can be increased when it is combined with Palbociclib.
Lenvatinib	Lenvatinib The serum concentration of Midazolam can be increased when it is combined with Lenvatinib.
Panobinostat	Panobinostat The metabolism of Panobinostat can be decreased when combined with Midazolam.
Haloperidol Injection	Haloperidol Injection The serum concentration of Midazolam can be increased when it is combined with Haloperidol.
Amiloride	Amiloride Amiloride may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection	Isavuconazonium Injection The serum concentration of Midazolam can be increased when it is combined with Isavuconazonium.
Macitentan	Macitentan Midazolam may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib	Sonidegib The metabolism of Sonidegib can be decreased when combined with Midazolam.
Flibanserin	Flibanserin The risk or severity of adverse effects can be increased when Midazolam is combined with Flibanserin.
Daclatasvir	Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Midazolam.
Brexpiprazole	Brexpiprazole The risk or severity of adverse effects can be increased when Midazolam is combined with Brexpiprazole.
Ziprasidone Injection	Ziprasidone Injection The serum concentration of Midazolam can be increased when it is combined with Ziprasidone.
Cariprazine	Cariprazine The risk or severity of adverse effects can be increased when Midazolam is combined with Cariprazine.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Midazolam may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline	Eluxadoline The risk or severity of adverse effects can be increased when Eluxadoline is combined with Midazolam.
Cobimetinib	Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Midazolam.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Midazolam.
Osimertinib	Osimertinib The serum concentration of Midazolam can be increased when it is combined with Osimertinib.
Alectinib	Alectinib The metabolism of Alectinib can be decreased when combined with Midazolam.
Ixazomib	Ixazomib The metabolism of Ixazomib can be decreased when combined with Midazolam.
Lesinurad	Lesinurad Midazolam may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection The serum concentration of Midazolam can be increased when it is combined with Amphotericin B.
Dexamethasone Injection	Dexamethasone Injection The serum concentration of Midazolam can be increased when it is combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection The risk or severity of adverse effects can be increased when Midazolam is combined with Brivaracetam.
Venetoclax	Venetoclax The serum concentration of Midazolam can be increased when it is combined with Venetoclax.
Cobicistat	Cobicistat The serum concentration of Midazolam can be increased when it is combined with Cobicistat.
Pimavanserin	Pimavanserin The risk or severity of adverse effects can be increased when Midazolam is combined with Pimavanserin.
Diphenhydramine Injection	Diphenhydramine Injection The risk or severity of adverse effects can be increased when Midazolam is combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection Midazolam may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib	Rucaparib The serum concentration of Midazolam can be increased when it is combined with Rucaparib.
Lixisenatide Injection	Lixisenatide Injection Midazolam may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib	Ribociclib The serum concentration of Midazolam can be increased when it is combined with Ribociclib.
Brigatinib	Brigatinib The metabolism of Brigatinib can be decreased when combined with Midazolam.
Doxepin (Insomnia)	Doxepin (Insomnia) Midazolam may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Deutetrabenazine	Deutetrabenazine The risk or severity of sedation and somnolence can be increased when Midazolam is combined with Deutetrabenazine.
Valbenazine	Valbenazine Midazolam may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort	Deflazacort The metabolism of Midazolam can be increased when combined with Deflazacort.
Safinamide	Safinamide The metabolism of Midazolam can be decreased when combined with Safinamide.
Naldemedine	Naldemedine Midazolam may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection	Sarilumab Injection The serum concentration of Midazolam can be increased when it is combined with Sarilumab.
Midostaurin	Midostaurin The serum concentration of Midazolam can be increased when it is combined with Midostaurin.
Neratinib	Neratinib The metabolism of Neratinib can be decreased when combined with Midazolam.
Enasidenib	Enasidenib The serum concentration of Midazolam can be increased when it is combined with Enasidenib.
Aprepitant/Fosaprepitant Injection	Aprepitant/Fosaprepitant Injection The serum concentration of Midazolam can be increased when it is combined with Fosaprepitant.
Benznidazole	Benznidazole Midazolam may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection	Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Midazolam.
Delafloxacin	Delafloxacin Midazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib	Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Midazolam.
Acalabrutinib	Acalabrutinib The serum concentration of Midazolam can be increased when it is combined with Acalabrutinib.
Letermovir	Letermovir The serum concentration of Midazolam can be increased when it is combined with Letermovir.
Tetrabenazine	Tetrabenazine The risk or severity of sedation and somnolence can be increased when Midazolam is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin Ertugliflozin may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection	Buprenorphine Injection The serum concentration of Midazolam can be increased when it is combined with Buprenorphine.
Apalutamide	Apalutamide Midazolam may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Fostamatinib	Fostamatinib The serum concentration of Midazolam can be increased when it is combined with Fostamatinib.
Baricitinib	Baricitinib The metabolism of Baricitinib can be decreased when combined with Midazolam.
Lofexidine	Lofexidine The therapeutic efficacy of Midazolam can be increased when used in combination with Lofexidine.
Plazomicin Injection	Plazomicin Injection Midazolam may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat	Eliglustat The metabolism of Eliglustat can be decreased when combined with Midazolam.
Ivosidenib	Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Midazolam.
Doravirine	Doravirine The metabolism of Doravirine can be decreased when combined with Midazolam.
Cannabidiol	Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Midazolam.
Dacomitinib	Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Midazolam.
Duvelisib	Duvelisib The metabolism of Duvelisib can be decreased when combined with Midazolam.
Stiripentol	Stiripentol The serum concentration of Midazolam can be increased when it is combined with Stiripentol.
Gilteritinib	Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Midazolam.
Lorlatinib	Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Midazolam.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Midazolam.
Rifamycin	Rifamycin The serum concentration of Midazolam can be increased when it is combined with Rifamycin.
Prucalopride	Prucalopride The metabolism of Prucalopride can be decreased when combined with Midazolam.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Midazolam can be increased when combined with Emapalumab.
Siponimod	Siponimod The metabolism of Siponimod can be decreased when combined with Midazolam.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Midazolam which could result in a higher serum level.
Erdafitinib	Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Midazolam.
Alpelisib	Alpelisib The serum concentration of Midazolam can be increased when it is combined with Alpelisib.
Brexanolone Injection	Brexanolone Injection The risk or severity of adverse effects can be increased when Midazolam is combined with Brexanolone.
Solriamfetol	Solriamfetol The risk or severity of adverse effects can be increased when Midazolam is combined with Solriamfetol.
Triclabendazole	Triclabendazole The serum concentration of Midazolam can be increased when it is combined with Triclabendazole.
Entrectinib	Entrectinib The metabolism of Entrectinib can be decreased when combined with Midazolam.
Pexidartinib	Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Midazolam.
Istradefylline	Istradefylline The serum concentration of Istradefylline can be increased when it is combined with Midazolam.
Pitolisant	Pitolisant The serum concentration of Midazolam can be decreased when it is combined with Pitolisant.
Lefamulin	Lefamulin The metabolism of Lefamulin can be decreased when combined with Midazolam.
Phenytoin Injection	Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Midazolam.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Midazolam.
Zanubrutinib	Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Midazolam.
Voxelotor	Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Midazolam.
Lumateperone	Lumateperone The risk or severity of adverse effects can be increased when Midazolam is combined with Lumateperone.
Lasmiditan	Lasmiditan The risk or severity of adverse effects can be increased when Midazolam is combined with Lasmiditan.
Tazemetostat	Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Midazolam.
Cenobamate	Cenobamate The serum concentration of Midazolam can be increased when it is combined with Cenobamate.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Midazolam.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Midazolam.
Remdesivir Injection	Remdesivir Injection The serum concentration of Midazolam can be increased when it is combined with Remdesivir.
Lemborexant	Lemborexant The risk or severity of adverse effects can be increased when Midazolam is combined with Lemborexant.
Daratumumab and Hyaluronidase-fihj Injection	Daratumumab and Hyaluronidase-fihj Injection The therapeutic efficacy of Midazolam can be decreased when used in combination with Hyaluronidase.
Fenfluramine	Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Midazolam.
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection	Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection The therapeutic efficacy of Midazolam can be decreased when used in combination with Hyaluronidase.
Octreotide	Octreotide The serum concentration of Midazolam can be increased when it is combined with Octreotide.
Pralsetinib	Pralsetinib The serum concentration of Midazolam can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Midazolam can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine	Viloxazine The risk or severity of adverse effects can be increased when Midazolam is combined with Viloxazine.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Theophylline	Theophylline The metabolism of Midazolam can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Midazolam which could result in a higher serum level.
Indomethacin	Indomethacin Indomethacin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Midazolam which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Midazolam which could result in a higher serum level.
Trazodone	Trazodone The risk or severity of adverse effects can be increased when Trazodone is combined with Midazolam.
Isotretinoin	Isotretinoin Midazolam may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate	Sucralfate Sucralfate may decrease the excretion rate of Midazolam which could result in a higher serum level.
Floxuridine	Floxuridine Floxuridine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Phenobarbital	Phenobarbital The risk or severity of adverse effects can be increased when Midazolam is combined with Phenobarbital.
Metaxalone	Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Midazolam.
Methotrexate Injection	Methotrexate Injection The metabolism of Midazolam can be decreased when combined with Methotrexate.
Levorphanol	Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Midazolam.
Primidone	Primidone The risk or severity of adverse effects can be increased when Midazolam is combined with Primidone.
Methsuximide	Methsuximide The risk or severity of adverse effects can be increased when Midazolam is combined with Methsuximide.
Diethylpropion	Diethylpropion The risk or severity of adverse effects can be increased when Midazolam is combined with Diethylpropion.
Chlorpromazine	Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Midazolam.
Diazepam	Diazepam The serum concentration of Midazolam can be increased when it is combined with Diazepam.
Oxazepam	Oxazepam The risk or severity of adverse effects can be increased when Midazolam is combined with Oxazepam.
Flurazepam	Flurazepam The risk or severity of adverse effects can be increased when Midazolam is combined with Flurazepam.
Clorazepate	Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Midazolam.
Lorazepam	Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Midazolam.
Carmustine	Carmustine Carmustine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Amantadine	Amantadine Midazolam may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine	Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.
Meprobamate	Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Midazolam.
Chlordiazepoxide	Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Midazolam.
Bromocriptine	Bromocriptine The serum concentration of Midazolam can be increased when it is combined with Bromocriptine.
Tranylcypromine	Tranylcypromine The serum concentration of Midazolam can be increased when it is combined with Tranylcypromine.
Phenelzine	Phenelzine The serum concentration of Midazolam can be increased when it is combined with Phenelzine.
Procarbazine	Procarbazine The risk or severity of adverse effects can be increased when Midazolam is combined with Procarbazine.
Ergoloid Mesylates	Ergoloid Mesylates The risk or severity of adverse effects can be increased when Midazolam is combined with Ergoloid mesylate.
Tetracycline	Tetracycline The serum concentration of Midazolam can be increased when it is combined with Tetracycline.
Minocycline	Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Prochlorperazine	Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Midazolam.
Thioridazine	Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Midazolam.
Trifluoperazine	Trifluoperazine The risk or severity of adverse effects can be increased when Midazolam is combined with Trifluoperazine.
Bleomycin	Bleomycin Bleomycin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dapsone	Dapsone The metabolism of Midazolam can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine Sulfadiazine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Oxycodone	Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Midazolam.
Methadone	Methadone Midazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Oxybutynin	Oxybutynin The serum concentration of Midazolam can be increased when it is combined with Oxybutynin.
Benztropine	Benztropine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline	Maprotiline The risk or severity of adverse effects can be increased when Midazolam is combined with Maprotiline.
Ibuprofen	Ibuprofen Ibuprofen may decrease the excretion rate of Midazolam which could result in a higher serum level.
Trihexyphenidyl	Trihexyphenidyl Midazolam may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine	Orphenadrine The serum concentration of Midazolam can be increased when it is combined with Orphenadrine.
Perphenazine	Perphenazine The risk or severity of adverse effects can be increased when Midazolam is combined with Perphenazine.
Azathioprine	Azathioprine Midazolam may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Fluphenazine	Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Midazolam.
Phentermine	Phentermine The metabolism of Phentermine can be decreased when combined with Midazolam.
Methylphenidate	Methylphenidate Methylphenidate may decrease the excretion rate of Midazolam which could result in a higher serum level.
Amoxapine	Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Midazolam.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Hydrocortisone	Hydrocortisone The metabolism of Hydrocortisone can be decreased when combined with Midazolam.
Doxorubicin	Doxorubicin The serum concentration of Midazolam can be increased when it is combined with Doxorubicin.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Carbamazepine	Carbamazepine The metabolism of Midazolam can be decreased when combined with Carbamazepine.
Molindone	Molindone The risk or severity of adverse effects can be increased when Midazolam is combined with Molindone.
Methyldopa	Methyldopa Midazolam may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine	Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Midazolam.
Hydralazine	Hydralazine The serum concentration of Midazolam can be increased when it is combined with Hydralazine.
Cimetidine	Cimetidine The serum concentration of Midazolam can be increased when it is combined with Cimetidine.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Warfarin	Warfarin The serum concentration of Warfarin can be increased when it is combined with Midazolam.
Clonazepam	Clonazepam The risk or severity of adverse effects can be increased when Midazolam is combined with Clonazepam.
Loperamide	Loperamide The serum concentration of Midazolam can be increased when it is combined with Loperamide.
Promethazine	Promethazine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Promethazine.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Daunorubicin	Daunorubicin The serum concentration of Midazolam can be increased when it is combined with Daunorubicin.
Nitrofurantoin	Nitrofurantoin Midazolam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin	Digoxin Midazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine	Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Midazolam.
Chloroquine	Chloroquine Chloroquine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Quinine	Quinine The serum concentration of Midazolam can be increased when it is combined with Quinine.
Ethosuximide	Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Midazolam.
Triamterene	Triamterene Triamterene may decrease the excretion rate of Midazolam which could result in a higher serum level.
Chlorothiazide	Chlorothiazide Chlorothiazide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone	Chlorthalidone Chlorthalidone may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone	Metolazone Metolazone may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection	Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Midazolam.
Secobarbital	Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Midazolam.
Desipramine	Desipramine The serum concentration of Midazolam can be increased when it is combined with Desipramine.
Amitriptyline	Amitriptyline Midazolam may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Imipramine	Imipramine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
Probenecid	Probenecid Midazolam may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine	Quinidine The serum concentration of Midazolam can be increased when it is combined with Quinidine.
Procainamide	Procainamide Midazolam may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid	Isoniazid The serum concentration of Midazolam can be increased when it is combined with Isoniazid.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Rifampin	Rifampin The metabolism of Midazolam can be increased when combined with Rifampicin.
Disopyramide	Disopyramide Midazolam may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
Valproic Acid	Valproic Acid The serum concentration of Midazolam can be increased when it is combined with Valproic acid.
Tamoxifen	Tamoxifen The serum concentration of Midazolam can be increased when it is combined with Tamoxifen.
Butabarbital	Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Midazolam.
Liothyronine	Liothyronine Liothyronine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Methimazole	Methimazole The serum concentration of Midazolam can be increased when it is combined with Methimazole.
Chlorpropamide	Chlorpropamide Chlorpropamide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Tolbutamide	Tolbutamide Midazolam may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide	Tolazamide Midazolam may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Dextromethorphan	Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Midazolam.
Cyclobenzaprine	Cyclobenzaprine The risk or severity of CNS depression can be increased when Midazolam is combined with Cyclobenzaprine.
Baclofen	Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Midazolam.
Doxylamine	Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Cyproheptadine	Cyproheptadine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
Clemastine	Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Midazolam.
Chlorpheniramine	Chlorpheniramine The risk or severity of adverse effects can be increased when Midazolam is combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Midazolam.
Meclizine	Meclizine The risk or severity of adverse effects can be increased when Midazolam is combined with Meclizine.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Methyclothiazide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide	Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dantrolene	Dantrolene The risk or severity of adverse effects can be increased when Midazolam is combined with Dantrolene.
Chlorzoxazone	Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Midazolam.
Carisoprodol	Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Midazolam.
Methocarbamol	Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Midazolam.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Danazol	Danazol The serum concentration of Midazolam can be increased when it is combined with Danazol.
Disulfiram	Disulfiram The metabolism of Disulfiram can be decreased when combined with Midazolam.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Nortriptyline	Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Midazolam.
Spironolactone	Spironolactone Spironolactone may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection	Amphotericin B Injection The serum concentration of Midazolam can be increased when it is combined with Amphotericin B.
Mercaptopurine	Mercaptopurine The therapeutic efficacy of Midazolam can be decreased when used in combination with Mercaptopurine.
Phytonadione	Phytonadione Midazolam may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Nadolol	Nadolol Midazolam may decrease the excretion rate of Nadolol which could result in a higher serum level.
Butorphanol Injection	Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Midazolam.
Nalbuphine Injection	Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Midazolam.
Allopurinol	Allopurinol Allopurinol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Trimethobenzamide	Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Midazolam.
Flavoxate	Flavoxate Midazolam may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Colchicine	Colchicine The serum concentration of Colchicine can be increased when it is combined with Midazolam.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dacarbazine	Dacarbazine Midazolam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide	Acetazolamide The serum concentration of Midazolam can be increased when it is combined with Acetazolamide.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Midazolam which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Ketoconazole	Ketoconazole The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.
Pyrantel	Pyrantel The risk or severity of adverse effects can be increased when Midazolam is combined with Pyrantel.
Thiotepa Injection	Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Midazolam.
Vincristine Injection	Vincristine Injection The metabolism of Midazolam can be decreased when combined with Vincristine.
Vinblastine	Vinblastine The serum concentration of Midazolam can be increased when it is combined with Vinblastine.
Ethacrynic Acid	Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Midazolam which could result in a higher serum level.
Metoprolol	Metoprolol The metabolism of Midazolam can be decreased when combined with Metoprolol.
Hydroxyzine	Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Thiothixene	Thiothixene The risk or severity of adverse effects can be increased when Midazolam is combined with Thiothixene.
Aspirin	Aspirin Acetylsalicylic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Midazolam which could result in a higher serum level.
Alprazolam	Alprazolam The metabolism of Alprazolam can be decreased when combined with Midazolam.
Temazepam	Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Midazolam.
Triazolam	Triazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Triazolam.
Dicyclomine	Dicyclomine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine	Hyoscyamine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline	Propantheline Midazolam may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim	Trimethoprim Trimethoprim may decrease the excretion rate of Midazolam which could result in a higher serum level.
Diltiazem	Diltiazem The serum concentration of Midazolam can be increased when it is combined with Diltiazem.
Nifedipine	Nifedipine Midazolam may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol	Timolol Timolol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Verapamil	Verapamil The serum concentration of Midazolam can be increased when it is combined with Verapamil.
Pindolol	Pindolol The risk or severity of adverse effects can be increased when Midazolam is combined with Pindolol.
Cisplatin Injection	Cisplatin Injection Midazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Midazolam which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Midazolam which could result in a higher serum level.
Bumetanide	Bumetanide Midazolam may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Etoposide	Etoposide The serum concentration of Midazolam can be increased when it is combined with Etoposide.
Glyburide	Glyburide The serum concentration of Midazolam can be increased when it is combined with Glyburide.
Glipizide	Glipizide Midazolam may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide	Indapamide Indapamide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin	Amoxicillin Midazolam may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection	Oxacillin Injection Midazolam may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline	Pentoxifylline The therapeutic efficacy of Midazolam can be decreased when used in combination with Pentoxifylline.
Pentamidine Injection	Pentamidine Injection Pentamidine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Midazolam which could result in a higher serum level.
Labetalol	Labetalol Labetalol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Auranofin	Auranofin Midazolam may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection Leuprolide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Gemfibrozil	Gemfibrozil Midazolam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Midazolam which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Midazolam which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Midazolam which could result in a higher serum level.
Pimozide	Pimozide The serum concentration of Midazolam can be increased when it is combined with Pimozide.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Midazolam which could result in a higher serum level.
Amiodarone	Amiodarone The serum concentration of Midazolam can be increased when it is combined with Amiodarone.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Midazolam which could result in a higher serum level.
Buspirone	Buspirone Buspirone may decrease the excretion rate of Midazolam which could result in a higher serum level.
Lovastatin	Lovastatin The serum concentration of Midazolam can be increased when it is combined with Lovastatin.
Ciprofloxacin	Ciprofloxacin The serum concentration of Midazolam can be increased when it is combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Diclofenac	Diclofenac Diclofenac may decrease the excretion rate of Midazolam which could result in a higher serum level.
Fluoxetine	Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Midazolam.
Clozapine	Clozapine The serum concentration of Midazolam can be increased when it is combined with Clozapine.
Estazolam	Estazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Estazolam.
Didanosine	Didanosine Midazolam may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection	Pentostatin Injection Pentostatin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Clarithromycin	Clarithromycin The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Midazolam which could result in a higher serum level.
Felodipine	Felodipine The serum concentration of Midazolam can be increased when it is combined with Felodipine.
Fosinopril	Fosinopril Fosinopril may decrease the excretion rate of Midazolam which could result in a higher serum level.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Midazolam which could result in a higher serum level.
Simvastatin	Simvastatin The metabolism of Midazolam can be decreased when combined with Simvastatin.
Teniposide Injection	Teniposide Injection The serum concentration of Midazolam can be increased when it is combined with Teniposide.
Itraconazole	Itraconazole The metabolism of Midazolam can be decreased when combined with Itraconazole.
Lisinopril	Lisinopril Midazolam may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Bisoprolol	Bisoprolol Bisoprolol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Zolpidem	Zolpidem Midazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin	Doxazosin The metabolism of Doxazosin can be decreased when combined with Midazolam.
Isradipine	Isradipine The serum concentration of Midazolam can be increased when it is combined with Isradipine.
Omeprazole	Omeprazole The serum concentration of Midazolam can be increased when it is combined with Omeprazole.
Cisapride	Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Midazolam.
Gabapentin	Gabapentin The risk or severity of adverse effects can be increased when Midazolam is combined with Gabapentin.
Fluvastatin	Fluvastatin The serum concentration of Midazolam can be increased when it is combined with Fluvastatin.
Venlafaxine	Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Midazolam.
Famciclovir	Famciclovir The metabolism of Famciclovir can be decreased when combined with Midazolam.
Fluvoxamine	Fluvoxamine The serum concentration of Midazolam can be increased when it is combined with Fluvoxamine.
Nefazodone	Nefazodone The serum concentration of Midazolam can be increased when it is combined with Nefazodone.
Lamotrigine	Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Midazolam.
Losartan	Losartan The serum concentration of Midazolam can be increased when it is combined with Losartan.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Midazolam which could result in a higher serum level.
Tramadol	Tramadol The metabolism of Midazolam can be decreased when combined with Tramadol.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Midazolam.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Lansoprazole	Lansoprazole The serum concentration of Midazolam can be increased when it is combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection The serum concentration of Midazolam can be increased when it is combined with Ifosfamide.
Nicardipine	Nicardipine The serum concentration of Midazolam can be increased when it is combined with Nicardipine.
Bupropion	Bupropion The risk or severity of adverse effects can be increased when Midazolam is combined with Bupropion.
Ticlopidine	Ticlopidine The metabolism of Midazolam can be decreased when combined with Ticlopidine.
Saquinavir	Saquinavir The serum concentration of Midazolam can be increased when it is combined with Saquinavir.
Metformin	Metformin Metformin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Nisoldipine	Nisoldipine The metabolism of Midazolam can be decreased when combined with Nisoldipine.
Lamivudine	Lamivudine Midazolam may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole	Riluzole The risk or severity of adverse effects can be increased when Midazolam is combined with Riluzole.
Acarbose	Acarbose Acarbose may decrease the excretion rate of Midazolam which could result in a higher serum level.
Gemcitabine Injection	Gemcitabine Injection Gemcitabine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Indinavir	Indinavir The serum concentration of Midazolam can be increased when it is combined with Indinavir.
Ritonavir	Ritonavir The serum concentration of Midazolam can be increased when it is combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection The serum concentration of Midazolam can be increased when it is combined with Docetaxel.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Midazolam which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Midazolam may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine	Clomipramine The metabolism of Clomipramine can be decreased when combined with Midazolam.
Zafirlukast	Zafirlukast The serum concentration of Midazolam can be increased when it is combined with Zafirlukast.
Fosfomycin	Fosfomycin Midazolam may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine	Mirtazapine The serum concentration of Midazolam can be increased when it is combined with Mirtazapine.
Topiramate	Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Midazolam.
Pramipexole	Pramipexole Midazolam may increase the sedative activities of Pramipexole.
Donepezil	Donepezil The risk or severity of adverse effects can be increased when Midazolam is combined with Donepezil.
Nelfinavir	Nelfinavir The serum concentration of Midazolam can be increased when it is combined with Nelfinavir.
Azithromycin	Azithromycin The metabolism of Azithromycin can be decreased when combined with Midazolam.
Nilutamide	Nilutamide Nilutamide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Flutamide	Flutamide Flutamide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Selegiline	Selegiline The risk or severity of adverse effects can be increased when Midazolam is combined with Selegiline.
Bicalutamide	Bicalutamide The serum concentration of Midazolam can be increased when it is combined with Bicalutamide.
Sertraline	Sertraline The risk or severity of adverse effects can be increased when Midazolam is combined with Sertraline.
Raloxifene	Raloxifene The serum concentration of Midazolam can be increased when it is combined with Raloxifene.
Irbesartan	Irbesartan The serum concentration of Midazolam can be increased when it is combined with Irbesartan.
Tamsulosin	Tamsulosin Midazolam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole	Ropinirole Midazolam may increase the sedative activities of Ropinirole.
Finasteride	Finasteride The metabolism of Finasteride can be decreased when combined with Midazolam.
Quetiapine	Quetiapine The risk or severity of adverse effects can be increased when Midazolam is combined with Quetiapine.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Midazolam which could result in a higher serum level.
Cetirizine	Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Midazolam.
Paroxetine	Paroxetine The serum concentration of Midazolam can be increased when it is combined with Paroxetine.
Tolcapone	Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Midazolam.
Citalopram	Citalopram The serum concentration of Midazolam can be increased when it is combined with Citalopram.
Capecitabine	Capecitabine Midazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz	Efavirenz The serum concentration of Midazolam can be increased when it is combined with Efavirenz.
Abacavir	Abacavir Midazolam may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil	Sildenafil The metabolism of Midazolam can be decreased when combined with Sildenafil.
Celecoxib	Celecoxib Celecoxib may decrease the excretion rate of Midazolam which could result in a higher serum level.
Rosiglitazone	Rosiglitazone Rosiglitazone may decrease the excretion rate of Midazolam which could result in a higher serum level.
Tolterodine	Tolterodine Midazolam may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide	Thalidomide Midazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Midazolam which could result in a higher serum level.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Midazolam which could result in a higher serum level.
Nateglinide	Nateglinide Midazolam may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Levetiracetam	Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Midazolam.
Rabeprazole	Rabeprazole The serum concentration of Midazolam can be increased when it is combined with Rabeprazole.